Merck KGaA ROCE 2024

Merck KGaA ROCE

0.16

Merck KGaA Dividend yield

1.45 %

Ticker

MRK.DE

ISIN

DE0006599905

WKN

659990

In 2024, Merck KGaA's return on capital employed (ROCE) was 0.16, a -21.92% increase from the 0.2 ROCE in the previous year.

Merck KGaA Aktienanalyse

What does Merck KGaA do?

Merck is one of the oldest and most well-known companies in the pharmaceutical and chemical industry. It was founded as a pharmacy in Darmstadt in 1668 and has since developed into a global company that is successful worldwide. Merck's business model is based on various business areas, all of which are based on scientific research and innovation. The three main business areas are the Life Science, Healthcare, and Performance Materials divisions, all of which focus on providing products and services for a wide range of industries. Life Science is Merck's largest business area, focusing on providing materials, products, instruments, and services for scientific research and biopharmaceutical production. The company offers a wide range of products that focus on the work of researchers and scientists in molecular biology, cell technology, and genomics. Healthcare is another important business area for Merck, focusing on the manufacture and marketing of innovative drugs and treatments for patients. The company offers products for the treatment of diseases such as cancer, multiple sclerosis, and schizophrenia. Performance Materials is Merck's third business area, specializing in the production of materials and technologies for various industries such as the automotive industry, electronics, and packaging. The company focuses on the development of innovative materials such as liquid crystals and organic photovoltaic materials. Merck is also known for its research and development, and the company invests significant resources in developing new products and technologies. This is also evident in the extensive portfolio of products offered by Merck. The company offers a wide range of products ranging from laboratory and analysis equipment to pharmaceuticals and biopharmaceuticals to specialty chemicals. An example of an important product from Merck is the rheumatoid arthritis drug Remicade, which was developed in collaboration with Johnson & Johnson. Merck is also one of the leading manufacturers of liquid crystals for use in displays and electronic devices. Merck is a company committed to social responsibility and sustainability. The company is involved in many areas, including environmental, social, and governance issues. Merck is committed to developing sustainable products and technologies and is dedicated to promoting education, health, and social justice in the communities where it operates. Overall, Merck is a leading company in the pharmaceutical and chemical industry, known for its innovation, research and development, as well as its social responsibility and sustainability. With currently approximately 58,000 employees and annual sales of 17.4 billion euros, the global company network is represented in 67 countries and demonstrates the quality and capabilities of the company worldwide. Merck KGaA ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Merck KGaA revenue by segment

In the annual report of the Merck KGaA share (DE0006599905, 659990, MRK.DE), it breaks down its revenues into 3 segments: 1. Life Science, 2. Healthcare, 3. Performance Materials. The Merck KGaA stock (WKN: 659990, ISIN: DE0006599905, Ticker Symbol: MRK.DE) is a leading investment for investors interested in participating in the Health Care sector.

ROCE Details

Unraveling Merck KGaA's Return on Capital Employed (ROCE)

Merck KGaA's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Merck KGaA's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Merck KGaA's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Merck KGaA’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Merck KGaA Stock

What is the ROCE (Return on Capital Employed) of Merck KGaA this year?

The ROCE of Merck KGaA is 0.16 undefined this year.

How has the ROCE (Return on Capital Employed) of Merck KGaA developed compared to the previous year?

The ROCE of Merck KGaA has increased by -21.92% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Merck KGaA?

A high Return on Capital Employed (ROCE) indicates that Merck KGaA has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Merck KGaA?

A low ROCE (Return on Capital Employed) can indicate that Merck KGaA has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Merck KGaA impact the company?

An increase in the ROCE of Merck KGaA can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Merck KGaA affect the company?

A decrease in ROCE of Merck KGaA can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Merck KGaA?

Some factors that can affect Merck KGaA's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Merck KGaA so important for investors?

The ROCE of Merck KGaA is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Merck KGaA take to improve the ROCE?

To improve the ROCE, Merck KGaA can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Merck KGaA pay?

Over the past 12 months, Merck KGaA paid a dividend of 2.2 EUR . This corresponds to a dividend yield of about 1.45 %. For the coming 12 months, Merck KGaA is expected to pay a dividend of 2.42 EUR.

What is the dividend yield of Merck KGaA?

The current dividend yield of Merck KGaA is 1.45 %.

When does Merck KGaA pay dividends?

Merck KGaA pays a quarterly dividend. This is distributed in the months of May, May, June, May.

How secure is the dividend of Merck KGaA?

Merck KGaA paid dividends every year for the past 0 years.

What is the dividend of Merck KGaA?

For the upcoming 12 months, dividends amounting to 2.42 EUR are expected. This corresponds to a dividend yield of 1.59 %.

In which sector is Merck KGaA located?

Merck KGaA is assigned to the 'Health' sector.

Wann musste ich die Aktien von Merck KGaA kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Merck KGaA from 5/2/2024 amounting to 2.2 EUR, you needed to have the stock in your portfolio before the ex-date on 4/29/2024.

When did Merck KGaA pay the last dividend?

The last dividend was paid out on 5/2/2024.

What was the dividend of Merck KGaA in the year 2023?

In the year 2023, Merck KGaA distributed 1.85 EUR as dividends.

In which currency does Merck KGaA pay out the dividend?

The dividends of Merck KGaA are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Merck KGaA stock can be added to a savings plan with the following providers: Trade Republic, ING, Scalable Capital and Consorsbank

Andere Kennzahlen von Merck KGaA

Our stock analysis for Merck KGaA Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Merck KGaA Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.